TDO-IN-2
TDO-IN-2 (Compound 5c) is an orally active TDO inhibitor (IC50: 1.25 μM). TDO-IN-2 has antitumor activity in the Hepa1-6 hepatocellular carcinoma allograft mouse model. TDO-IN-2 has synergistic effects with the PD-1/PD-L1 inhibitor BMS-202 and can be used to study tumor immune tolerance[1].
Product Specifications
UNSPSC
12352211
Target
Indoleamine 2,3-Dioxygenase (IDO)
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(/C(C#N)=C/C1=CNC2=CC=CC=C12)NC3=CC(OCCO4)=C4C=C3
Molecular Formula
C20H15N3O3
Molecular Weight
345.35
References & Citations
[1]Wang X, et al. Discovery of (E) -2-cyano-N- (2,3-dihydrobenzo[b][1,4] dioxin-6-yl) -3- (1H-indol-3-yl) acrylamide as a novel TDO inhibitor for cancer treatment. Bioorg Chem. 2025 May 5;161:108555.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2230102 1.0 µg DNA
SNORD55 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details GTR10388075 96 Well
Porcine Olfactory receptor 1F1 (OR1F1) ELISA kit
Sign In for Pricing
View Details 
MBS960172-01 0.02 mg (Yeast)
Recombinant Human Hypoxia-inducible factor 1-alpha protein
Sign In for Pricing
View Details MBS960172-02 0.1 mg (Yeast)
Recombinant Human Hypoxia-inducible factor 1-alpha protein
Sign In for Pricing
View Details MBS960172-03 1 mg (Yeast)
Recombinant Human Hypoxia-inducible factor 1-alpha protein
Sign In for Pricing
View Details